Table 1.

Immunological characteristics of the patient.

	Patient	Reference values
Age at evaluation (years)	16
Lymphocytes (/μl)	2,573	1,849–2,788
Natural killer cells (CD16+CD56+) (/μl)	387	70–480
T cells (CD3+) (/μl)	2,213	1,000–2,200
CD4 T cells (/μl)	515	530–1,300
CD8 T cells (/μl)	1,570	330–920
Naive CD4 T cells (CD45RA+/CD4+) (%)	35	58–70
Naive CD4 recent thymic emigrants T cells (CD31+CD45RA+/CD4+)	19	43–55
Naive CD8 T cells (CCR7+CD45RA+CD8+) (%)	4	52–68
Central memory CD8 T cells (CCR7+CD45RA–/CD8+) (%)	2.5	3–4
Effector memory CD8 T cells (CCR7–CD45RA–/CD8+) (%)	35	11–20
Terminal differentiating effector memory CD8 T cells (CCR7–CD45RA+/CD8+) (%)	58.5	16–28
B cells CD19 (/μl)	48	183–628
Transitional B cells (CD24++CD38++/CD19+) (%)	33	<11
Age at evaluation (years)	2	16
IgG (g/L)	<0.33 (3.7–15.8)	10.09* (6–16)
IgA (g/L)	0.81 (0.3–1.3)	2.07 (0.8–2.8)
IgM (g/L)	2.73 (0.5–2.2)	6.14 (0.5–1.9)

^*Under Ig replacement; age-matched Ig reference values in brackets.